Insmed shares jump more than 6% on report Sanofi is weighing acquisition
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Insmed belongs to, so it often moves with news about it.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+12.0% 30d
AbbVie is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.5% 30d
Merck is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+10.0% 30d
Abbott Laboratories is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.
- NVS Novartis AG
Novartis AG is a peer of Sanofi in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+19.9% 30d
AstraZeneca is a peer of Sanofi in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| INSMPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| SNYPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| XLVPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| LLYPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| JNJPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| ABBVPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| MRKPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| ABTPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| NVSPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| AZNPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Insmed shares jump more than 6% on report Sanofi is weighing acquisition Investing.com
Source: Investing.com
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 16 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 30 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 76 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 43 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 50 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 43 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 66 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 76 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 43 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 48 days before publication. Filed 27 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Insmed shares jump more than 6% on report Sanofi is weighing acquisition” scores 12 out of 100. The score uses 1 source.